{
  "catalogId": "faeeaa84-3832-41e8-8df8-2225f475de16",
  "name": "RECORLEV",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "174 69 37497 99",
  "treatmentDescriptions": "RECORLEV is indicated for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative.RECORLEV is not approved for the treatment of fungal infections. The safety and effectiveness of RECORLEV for the treatment of fungal infections have not been established.",
  "termsOfIssue": "Prescription required",
  "form": "tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "LEVOKETOCONAZOLE",
  "codes": {},
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "RECORLEV 150MG 50 TABS",
      "manufacturer": {
        "name": "ניאופרם",
        "countryOfOrigin": "IL"
      },
      "strength": [],
      "quantity": {
        "value": 50.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE HDPE",
      "shelfLife": "60",
      "storageConditions": "",
      "codes": {
        "moh": "9239",
        "yarpa": "43135",
        "pharmasoft": "18684"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": "",
        "retailMargin": "",
        "maxRetailPrice": "",
        "maxPriceWithVAT": ""
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:52.002881"
  }
}